Futurity

Synthetic proteins mimic the real thing

Synthetic proteins with improved properties could fight infection, help treat diseases, and more.
woman working in the lab (synthetic proteins concept)

Researchers are creating synthetic versions of proteins with improved properties.

Imagine synthetic antibiotics that could fight infections like MRSA, custom pharmaceuticals to treat advanced prostate cancer, and new enzymes that will turn cellulose into fuel.

Chemist Kent Kirshenbaum and his team at New York University are engineering molecules to mimic the shape, structure, and function of natural proteins.

“We’ve really developed the building block approach to crafting these molecules in an extremely reliable way,” Kirshenbaum says. “We’re confident that if we can design a molecule, we’re going to be able to build it.”

The ultimate goal of this biomimetic chemistry research is to develop a reliable way to build synthetic proteins that can be put to work at the industrial scale.

The National Science Foundation funded the work.

Source: National Science Foundation

The post Synthetic proteins mimic the real thing appeared first on Futurity.

Altro da Futurity

Futurity3 min lettiPsychology
Blood Test For Depression Could Personalize Treatment
New research sheds light on the biological basis of mood disorders and offers a promising blood test for depression aimed at a precision-medicine approach to treatment. Worldwide, 1 in 4 people will suffer from a depressive episode in their lifetime,
Futurity2 min lettiMedical
Bariatric Surgery Cuts Cancer Risk For Some People With Obesity
Bariatric surgery can significantly reduce the risk of cancer—especially obesity-related cancers—by as much as half in certain people, a new study shows. The research, published in the journal Gastroenterology, is the first to show bariatric surgery
Futurity4 min lettiMedical
What Will Life Look Like After Most People Get The Vaccine?
Since the COVID-19 virus was discovered, the world has waited for a vaccine that would help our lives return to some level of normalcy. Now that vaccine distribution has begun, what will this “new normal” look like? Here, University of Chicago expert